Sort
48,018 grants matching “immunotherapy”
T-PHARMACYTES FOR PROSTATE CANCER IMMUNOTHERAPY
$382,428Massachusetts Institute Of Technology · · FY2010 · Department of the Army
Identification of Melanoma Brain Metastasis Tumor Biomarkers
$382,423Dave S B Hoon · Saint John'S Cancer Institute · R01 · FY2016 · CA
Identification of Melanoma Brain Metastasis Tumor Biomarkers
$382,423Dave S B Hoon · Saint John'S Cancer Institute · R01 · FY2017 · CA
Identification of Melanoma Brain Metastasis Tumor Biomarkers
$382,423Dave S B Hoon · Saint John'S Cancer Institute · R01 · FY2015 · CA
Interleukin-2 and autoimmune disease
$382,388Abul K. Abbas · University Of California, San Francisco · R01 · FY2010 · AI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$382,343William E Gillanders · Washington University · P50 · FY2019 · CA
Development of Highly Multiplex Antigen Specificity Assays
$382,333Harry Benjamin Larman · Johns Hopkins University · U24 · FY2019 · AI
Gene Transfer and Somatic Cell Enginerring
$382,320Isabelle Riviere · Sloan-Kettering Inst Can Research · P30 · FY2019 · CA
Regulation of memory T cell trafficking by core 2 O-glycan synthesis
$382,270Jeffrey C. Nolz · Oregon Health & Science University · R01 · FY2017 · AI
Regulation of memory T cell trafficking by core 2 O-glycan synthesis
$382,270Jeffrey C. Nolz · Oregon Health & Science University · R01 · FY2020 · AI
Regulation of memory T cell trafficking by core 2 O-glycan synthesis
$382,270Jeffrey C. Nolz · Oregon Health & Science University · R01 · FY2019 · AI
Regulation of memory T cell trafficking by core 2 O-glycan synthesis
$382,270Jeffrey C. Nolz · Oregon Health & Science University · R01 · FY2018 · AI
Regulation of memory T cell trafficking by core 2 O-glycan synthesis
$382,270Jeffrey C. Nolz · Oregon Health & Science University · R01 · FY2021 · AI
Cytokine Gene Expression During In Vivo Immune Response
$382,239William Clark Gause · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · AI
Cytokine Gene Expression During In Vivo Immune Response
$382,239William Clark Gause · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2012 · AI
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy
$382,222Ralph A. Reisfeld · Scripps Research Institute, The · R01 · FY2011 · CA
Cancer and Leukemia Group B - The Ohio State University
$382,209Ohio State University · U10 · FY2004 · CA
Machine Learning-Assisted Integrated Optofluidic Nanoplasmonic Biosensing for Precision Immune Profiling and Monitoring
$382,203Pengyu Chen · Auburn University At Auburn · R35 · FY2025 · GM
Controlled Release of Macromolecules
$382,200Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2015 · EB
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
$382,200Xinshu Grace Xiao · University Of California Los Angeles · R01 · FY2023 · CA
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2020 · HL
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2018 · HL
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2019 · HL
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2021 · HL
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
$382,146David McDermott · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA